Bruno Douradinha

Associate Professor & Senior Group Leader in Vaccinology

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bruno Douradinha is an Associate Professor and Senior Group Leader in Vaccinology at the University of Oxford, UK. His research encompasses a range of topics including Zika virus vaccines, the implications of mRNA vaccines, and the immune response to malaria. He has published recent articles addressing infectious diseases, vaccine development, and potential therapeutic approaches for various conditions.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (1)

Alessandra Mularoni

Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bruno Douradinha

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Infectious diseases and discrimination: Sicily’s Lampedusa migrants

Orthoflavivirus zikaense (Zika) vaccines: What are we waiting for?

Have mRNA vaccines sentenced DNA vaccines to death?

Does hydrogen peroxide contribute to the immunity against Malaria induced by whole attenuated plasmodial sporozoites?

Biographical Feature: In memoriam Reinhard Glück (1950–2021)—Swiss by birth, Sicilian by choice

Does attenuated plasmodial sporozoite-mediated protection require peroxynitrite?

Computational design and characterization of a multiepitope vaccine against carbapenemase-producing <i>Klebsiella pneumoniae</i> strains, derived from antigens identified through reverse vaccinology.

Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches.

Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis

Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment

<i>Klebsiella pneumoniae</i> Lipopolysaccharides Serotype O2afg Induce Poor Inflammatory Immune Responses Ex Vivo

Collaborators (1)

Alessandra Mularoni

Make your next move.